NIRMAN

Nirman Agri Genetics Share Price

₹411.00 +19.55 (4.99%)

21 Nov, 2024 14:09

SIP TrendupStart SIP in NIRMAN

Start SIP

Performance

  • Low
  • ₹403
  • High
  • ₹403
  • 52 Week Low
  • ₹158
  • 52 Week High
  • ₹484
  • Open Price₹0
  • Previous Close₹411
  • Volume13,500

Investment Returns

  • Over 1 Month + 20.7%
  • Over 3 Month + 2.52%
  • Over 6 Month + 94.79%
  • Over 1 Year + 88.14%
SIP Lightning

Smart Investing Starts Here Start SIP with Nirman Agri Genetics for Steady Growth!

Invest Now

Nirman Agri Genetics Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 18.4
  • PEG Ratio
  • -
  • Market Cap Cr
  • 329
  • P/B Ratio
  • 8.8
  • Average True Range
  • 19.77
  • EPS
  • 22.39
  • Dividend Yield
  • 0.5
  • MACD Signal
  • 1.04
  • RSI
  • 69.62
  • MFI
  • 80.28

Nirman Agri Genetics Financials

Nirman Agri Genetics Technicals

EMA & SMA

Current Price
₹411.00
+ 19.55 (4.99%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹357.16
  • 50 Day
  • ₹356.07
  • 100 Day
  • ₹346.06
  • 200 Day
  • ₹310.04

Resistance and Support

411 Pivot Speed
  • R3 411.00
  • R2 411.00
  • R1 411.00
  • S1 411.00
  • S2 411.00
  • S3 411.00

What's your outlook on Nirman Agri Genetics?

You can only vote for once

Ratings

Master Rating

EPS Strenth

N/A

Price Strength

Buyer Demand

Group Rank

Nirman Agri Genetics has an operating revenue of Rs. 151.80 Cr. on a trailing 12-month basis. An annual revenue growth of 121% is outstanding, Pre-tax margin of 17% is great, ROE of 27% is exceptional. The company is debt free and has a strong balance sheet enabling it to report stable earnings growth across business cycles. The stock from a technical standpoint is comfortably placed above its key moving averages, around 16% and 44% from 50DMA and 200DMA. It is currently FORMING a base in its weekly chart and is trading around 15% away from the crucial pivot point. From an O'Neil Methodology perspective, the stock has an EPS Rank of 0 which is a POOR score indicating inconsistency in earnings, a RS Rating of 87 which is GOOD indicating the outperformance as compared to other stocks, Buyer Demand at B- which is evident from recent demand for the stock, Group Rank of 103 indicates it belongs to a poor industry group of Agricultural Operations and a Master Score of C is fair but needs to improve. Overall, the stock is lagging behind in earnings parameter, but excellent technical strength makes it a stock to examine in more detail.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Nirman Agri Genetics Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-11-14 Quarterly Results
2024-08-14 Others Other business matters issue of equity shares of Rs. 10/- in the ratio of 11:32 @ premium of Rs. 229/-.
2024-07-22 Others To consider Fund Raising issue of equity shares of Rs. 10/- in the ratio of 11:32 @ premium of Rs. 229/-.
2024-05-28 Nirman Agri Gentics
2024-02-14 Quarterly Results
Date Purpose Remarks
2024-09-25 INTERIM Rs.0.00 Interim Dividend of Rs. 2/- per equity share.

Nirman Agri Genetics F&O

Nirman Agri Genetics Shareholding Pattern

57.81%
0.03%
37.75%
4.41%

About Nirman Agri Genetics

  • NSE Symbol
  • NIRMAN
  • BSE Symbol
  • Managing Director
  • Mr. Pranav Kailas Bagal
  • ISIN
  • INE0OK701014

Similar Stocks to Nirman Agri Genetics

Nirman Agri Genetics FAQs

Nirman Agri Genetics share price is ₹411 As on 21 November, 2024 | 13:55

The Market Cap of Nirman Agri Genetics is ₹329.2 Cr As on 21 November, 2024 | 13:55

The P/E ratio of Nirman Agri Genetics is 18.4 As on 21 November, 2024 | 13:55

The PB ratio of Nirman Agri Genetics is 8.8 As on 21 November, 2024 | 13:55

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23